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ABSTRACT: Cone dystrophy with supernormal rod re-
sponse (CDSRR) is considered to be a very rare autoso-
mal recessive retinal disorder. CDSRR is associated with
mutations in KCNV2, a gene that encodes a modulatory
subunit (Kv8.2) of a voltage-gated potassium channel. In
this study, we found thatKCNV2mutations are present in
a substantial fraction (2.2–4.3%) of a sample of 367 inde-
pendent patients with a variety of initial clinical diagnoses
of cone malfunction, indicating that CDSRR is underdiag-
nosed and more common than previously thought. In total,
we identified 20 different KCNV2 mutations; 15 of them
are novel. A new finding of this study is the substantial
proportion of large deletions at the KCNV2 locus that ac-
counts for 15.5% of the mutant alleles in our sample. We
determined the breakpoints and size of all five different
deletions, which ranged between 10.9 and 236.8 kb. Two
deletions encompass the entire KCNV2 gene and one also
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includes the adjacent VLDLR gene. Furthermore, we in-
vestigated N-terminal amino acid substitution mutations
for its effect on interaction with Kv2.1 using yeast two-
hybrid technology.We found that these mutations dramat-
ically reduce or abolish this interaction suggesting a lack
of assembly of heteromeric Kv channels as one underlying
pathomechanism of CDSRR.
HumMutat 32:1398–1406, 2011. C© 2011Wiley Periodicals, Inc.
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Introduction
Mutations in the KCNV2 gene (MIM# 607604) has been re-
cently identified to cause a peculiar form inherited retinopathy
known as cone dystrophy associatedwith supernormal rod response
[CDSRR;MIM# 610356;Wu et al., 2006]. This apparently rare form
of cone dystrophy is characterized by a congenital or early child-
hood onset, with poor best-corrected visual acuity (VA), central
scotoma, marked photophobia, severe dyschromatopsia, and oc-
casionally nystagmus. Some patients complain of night blindness
from childhood onwards or develop night blindness in the later
stages of the disease. Fundus findings are highly variable, varying
fromminute discrete accentuation of the foveal reflexes to unspecific
granular changes in the macula; few patients develop foveal or mac-
ular retinal pigment epithelium (RPE) atrophy [Michaelides et al.,
2005; Wissinger et al., 2008]. A hallmark of CDSRR is the decreased
C© 2011 WILEY PERIODICALS, INC.
and delayed dark-adapted response to dim flashes in electroretino-
graphic (ERG) recordings, which contrasts with the supernormal
b-wave response at the highest levels of stimulation. In addition,
light-adapted responses to a bright flash and to 30-Hz flickers are
delayed and markedly decreased [Gouras et al., 1983; Michaelides
et al., 2005]. Several studies have shown that this autosomal reces-
sive inherited phenotype is rather exclusively linked to mutations
in KCNV2 [Ben-Salah et al., 2008; Robson et al., 2010; Sergouniotis
et al., 2011; Thiagalingam et al., 2007; Wissinger et al., 2008], and
thus strikingly different from the genetic heterogeneity observed
for the majority of inherited retinopathies. Up to now 30 differ-
ent mutations in KCNV2 have been reported. These are almost
exclusively small insertion or deletion mutations (so-called indels)
and missense or nonsense inducing point mutations. KCNV2 is
predominantly expressed in retinal photoreceptors, most likely in
both rods and cones [Czirja´k et al., 2007; Wu et al., 2006]. It en-
codes a member of the family of voltage-gated potassium channels
(Kv channels), representing a silent subunit (Kv8.2, according to
the IUPHAR nomenclature), that does not form functional chan-
nels on its own. It has been shown that Kv8.2 is able to assemble
with Kv2.1 to form functional heteromeric channels with proper-
ties distinct from Kv2.1 homomeric channels, including a shift in
the steady-state activation curve toward more negative potentials, a
lower threshold potential for activation, a shortened activation time,
and slower inactivation kinetics [Czirja´k et al., 2007]. Heteromeric
Kv2.1/Kv8.2 channels show characteristics that resemble the Ikx cur-
rent first observed in amphibian photoreceptors [Beech and Barnes,
1989]. A lack of Kv8.2, as a consequence of a mutation in KCNV2,
may affect important characteristics of the Ikx current, for instance a
sustained outwardpotassiumcurrent in the dark, thatmay influence
the photoreceptor membrane potential. However, the mechanisms
of dysfunction that link KCNV2mutations with the clinical picture
of CDSRR still remain to be elucidated.
Subjects, Material and Methods
Patients and familymemberswere recruited over a period ofmore
than 15 years at different clinical centers and venous blood samples
were collected after informed consent was obtained.
Ophthalmological Examination
Clinical diagnoses were based on standard ophthalmological ex-
amination including evaluation of ocular motility, VA, refraction,
color vision and visual field testing, anterior segment pathology us-
ing slit lamp examination, fundus examination followed by fundus
photography, autofluorescence imaging, and ERG recordings under
scotopic and photopic conditions.
Molecular Genetic Analyses
Total genomic DNA was isolated from peripheral blood sam-
ples according to standard procedures. Mutation screening of the
KCNV2 gene (cDNA reference sequence NM_133497.3) was car-
ried out by complete sequencing of the coding exons and flanking
intronic/untranslated region (UTR) sequences as described previ-
ously [Wissinger et al., 2008]. Small heterozygous indel mutations
that result in overlaid sequence traces were further confirmed by
cloning of PCR products and subsequent sequencing of plasmids
from single bacterial colonies.
Deletion breakpoints were bridged by long-distance PCR
(LD-PCR) amplifications followed by restriction mapping refine-
ment and finally covered by DNA sequencing applying primer-
walking strategy.
Copy number analysis for exon 1 of the KCNV2 gene was done
by quantitative PCR (qPCR) employing TaqMan technology with
a custom designed assay as described previously [Wissinger et al.,
2008]. Further copy number qPCRs for loci flanking KCNV2 were
performed as followsusing SYBRGreen for product detection: 20-μl
reactions containing 100 ng of genomic DNA, 500 nM of forward
and reverse primer, and 10-μl SYBR Green Master Mix (Roche Ap-
plied Science, Basel, Switzerland) were subjected to thermal cycling
with 5 min at 95◦C, followed by 45 cycles of 10 sec at 95◦C, 15 sec
at 59◦C and 30 sec at 72◦C on a Lightcycler 480 (Roche Applied
Science). An assay that amplifies a fragment at GAPDH was used
as reference. qPCRs were done in triplicate and mean Ct values
were used for calculations. The mean of the ΔCt values (Ct“Target” –
CtGAPDH) of two to four control samples were used as calibrator, and
ΔΔCt and 2–ΔΔCt values were calculated for the patient samples to
be assessed.
Comparative genome hybridizations (CGH) using a ready-made
chromosome 9 specific 385k oligonucleotide array (HG18 CHR9
FT; Roche NimbleGen Inc., Madison, WI) were carried out for
two individuals with larger heterozygous deletions at the KCNV2
locus. Prior to CGH, DNA samples were further purified by phe-
nol/chloroformextractionandchecked forDNAintegrityby agarose
gel electrophoresis. CGH was carried out as a commercial service at
Roche NimbleGen, Reykjavik, Iceland.
In order to assess homozygosity regions and potential segments of
identity-by-descent, we used restriction-enzyme digested genomic
DNA for hybridizations on Affymetrix 250k_NspI single nucleotide
polymorphism(SNP) arrays (Affymetrix, SantaClara,CA). Samples
were processed in accordance with the manufacturer’s instructions
and arrays were scanned with the Affymetrix GeneChip Scanner
3000 7G. Genotypes were called with Affymetrix Genotyping Con-
sole Software v2.1 (GTC) using the BRLMM algorithm with default
calling threshold of 0.5 and a prior size of 10,000 bases. Samples
were required to have a minimum Quality Control SNP call rate of
90%.
Yeast Two-Hybrid Interaction Assays
Yeast two-hybrid bait and prey constructs encoding N-terminal
fragments of KCNB1/Kv2.1 (amino acid residues 1–190) and
KCNV2/Kv8.2 (amino acid residues 1–257), and cloned into
pGBKT7 (as fusion with the Gal4 DNA binding domain) and
pGADT7 (as fusion with the Gal4 activation domain) were re-
ported by Ottschytsch et al. [2002] and were kindly provided by
Dr. Elke Bocksteins and Dr. Dirk Snyders (Laboratory of Molecular
Biophysics, Physiology, and Pharmacology, University of Antwerp,
Belgium). Missense mutations were introduced by in vitro muta-
genesis using the overlap extension strategy [Ho et al., 1989] and
confirmed by DNA sequencing. Purified plasmid DNA was used to
transform yeast strains Y2HGold and Y187 (Clontech/Takara Bio
Europe, Saint-Germain-en-Laye, France), applying standard pro-
tocols. Mated dipoid cells or co-transformed haploid cells were
streaked on double dropout (SD-Leu-Trp) and quadruple dropout
(SD-Leu-Trp-His-Ade) medium with or without aureobasidin A
(125 ng/μl) and X-α-Gal (40 μg/ml), and grown for 72–120 hr at
30◦C. β-Galactosidase activity resulting from yeast two-hybrid de-
pendent activation of the LacZ gene expression was determined in
lysates of co-transformed Y187 yeast cells using chlorophenyl red b-
galactopyranoside (CPRG; Sigma-Aldrich, Taufkirchen, Germany)
as substrate according to standard protocols. Mean values and stan-
dard deviations ofβ-Galactosidase activitywere calculated from two
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replicates of each of three independent yeast colonies using the for-
mula: 1,000 × OD570/(t × V × OD600) with t being the incubation
time, V being the dilution factor, and OD600 being the cell culture
density before harvesting of the cells.
Results
Screening of the KCNV2 Gene in Patients with an Initial
Diagnosis of Cone Dysfunction
Prior studies have shown that the phenotype of CDSRR is exclu-
sively linked to mutations in KCNV2. CDSRR was first described
in 1983 as a new disease entity [Gouras et al., 1983] and subse-
quently only few case reports and small patient series have been
reported, suggesting that CDSRR is a very rare condition. In or-
der to test whether CDSRR is underdiagnosed or whether KCNV2
mutations might also be involved in other retinal phenotypes, we
applied DNA sequencing to screen for mutations in this gene in
a large cohort of 367 independent patients initially referred to us
with various diagnoses of cone-related retinal dystrophies includ-
ing achromatopsia and blue cone monochromacy (n = 167), cone
dystrophy (n = 154), and cone-rod dystrophy (n = 43). Patients
diagnosed with achromatopsia or blue cone monochromacy were
preselected for the absence of mutations in at least CNGA3 and
CNGB3 [Kohl et al., 1998, 2000;Wissinger et al. 2001], and the cone
opsin gene cluster on Xq28, respectively. In addition, we also in-
cluded three families with CDSRR that were newly diagnosed since
our last study. The composition of the patient cohort is listed in
Supp. Table S1.
In all three new CDSRR cases, we found KCNV2 mu-
tations: a homozygous c.1381G>A/p.Gly461Arg mutation in
family ZD389 (two affected siblings), compound heterozy-
gous mutations, c.727C>T/p.Arg243Trp and c.794_795dupCC/
p.Ser266ProfsX57, in patient RCD425, and compound heterozy-
gous mutations, c.8_11del4/p.Lys3ArgfsX95 and c.775_795dup21/
p.Ala259_Ala265dup7, in the index patient of family RCD382 (see
Supp. Table S2 for the genotypes of all patients and Table 1 for a list
of all mutations and variants identified in this study). This further
emphasizes the specificity of the association between CDSRR and
KCNV2mutation.
In RCD382 (see Fig. 1A for the pedigree), the three sisters of the
father had a history of reduced vision with glare, nystagmus, night
vision problems since childhood and with maculopathy on external
ophthalmological examinations.One affected sisterwas investigated
clinically in detail in comparison with the index patient (Supp. Ta-
ble S3). At an age of 33 years she demonstrated fine horizontal
nystagmus, her VA was 0.03 in both eyes and isopters in Goldmann
visual field were constricted for V/4e and III/4e (no smaller/dimmer
targets detected). Optic discs appeared normal but her macula had
no physiological reflexes. ERGs had signs now known to be typ-
ical for mutations in KCNV2 as summarized in Supp. Table S3
[Friedburg et al., 2007]. The differential diagnosis at the time of in-
vestigation was achromatopsia or cone (rod) dystrophy. We found
that she and her affected sisters carry the c.775_795dup21 mu-
tation, and in addition a novel heterozygous missense mutation
c.989T>C/p.Phe330Ser. The later affects an evolutionary highly con-
served phenylalanine residue and was excluded in 75 healthy con-
trols, further supporting that three pathogenic KCNV2 mutations
segregate in this family (Fig. 1A).
Upon screening the sample of patients with an initial diagnosis
of other cone-related retinal dystrophies, we found single homozy-
gous or two heterozygous KCNV2mutations in a subset of patients:
in seven patients with an initial diagnosis of achromatopsia, four
patients with cone dystrophy, and one patient with cone-rod dystro-
phy.Mutations in these patients included two frameshift mutations,
two nonsense mutations, one in-frame 9-bp deletion, five missense
mutations, and several larger deletions, as described below (Table 1
and Supp. Table S2). None of the pointmutations or small indelmu-
tations were observed in healthy controls (n = 59–97). In addition,
we found 11 patients (four with a diagnosis of achromatopsia, five
with cone dystrophy, and two with cone-rod dystrophy) with sin-
gle heterozygous mutations. Except for a 9-bp in-frame duplication
(c.1133_1141dup/p.Arg386_Ile387dvp), all other single heterozy-
gous mutations represent missense substitutions that have not been
observed in other CDSRR patients or controls.
Considering only patients with homozygous or compound het-
erozygous KCNV2mutations, our results indicate that mutations in
KCNV2 account for about 2.2–4.3% of patients with various initial
diagnoses of cone dysfunction. Hence, we retrospectively reassessed
whether those cases differ from the phenotype ofCDSRR.We specif-
ically asked the ophthalmologists in charge, whether—based on the
genetic findings—a diagnosis of CDSRR would be more appropri-
ate or specific than the initial diagnosis. Based on follow-up ex-
aminations or reevaluation of available clinical data that was done
for 10 patients, the answer was positive for nine of these patients
(Supp. Table S2). There were different reasons why the patients
were initially diagnosed with other retinal dystrophies, for example
(1) unawareness of CDSRR, (2) typical features overlooked or not
adequately considered, (3) ERG response considered as an artifact,
and (4) low-quality ERGdata.Only one patient diagnosedwith cone
dystrophy, who carried twomissensemutations (c.491T>C/p.F164S
and c.1381G>A/p.G461R), did not fully qualify for a diagnosis of
CDSRR, since the bright flash responses in ERG recordings were
still in the normal range.
Identification and Characterization of Homozygous
Deletions in the KCNV2 Gene
We repeatedly failed to amplify KCNV2 exon 1 in two pa-
tients (from pedigrees CHRO417 and RCD307 in Fig. 1B), though
exon 2 and other genomic loci could be readily amplified. We
therefore reasoned that homozygous deletions might be present
in those patients. In fact, qPCR-based copy number analysis of
KCNV2 exon 1 in the mother in RCD307 revealed a 2–ΔΔCt value
of 0.48, that is, an about 50% reduced copy number. We fur-
ther pursued with sequence tag site (STS) content mapping and
LD-PCR experiments that eventually led to the identification of
a deletion of 10,909 bp that encompasses all but the first 18 bp
of the coding sequence of exon 1 and most parts of intron 2,
and a short 6-bp sequence insertion between the proximal and
distal breakpoint (c.19_1356+9571delinsCATTTG; Supp. Fig. S1).
Both the mother and the unaffected brother in RCD307 were het-
erozygous carriers for this mutation (Fig. 1B). Exactly the same
mutation was also present in the index patient in CHRO417. There
was no evidence of close consanguinity in either family. RCD307
originate from Southern Germany and CHRO417 from Hungary
and could not specify any relationship upon personal interview.
Still, we suspected a common origin of this very specific deletion +
insertion mutation. To evaluate this hypothesis, we performed a
comparative high-resolution 250k SNP array analysis with DNA
from both patients.We found that both showed significant intervals
of homozygosity on chromosome 9p24 (including the KCNV2 lo-
cus) of 8.3 Mb (patient CHRO417) and 1.2 Mb (patient RCD307),
respectively (Supp. Fig. S2). Yet, the region of shared SNP genotypes
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Figure 1. Selected families that segregate KCNV2 mutations. A: Pedigree of family RCD382, that segregates three KCNV2 mutations. The arrow
marks the index patient and asterisks indicate the patients for which detailed clinical data are provided in Supp. Table S3. B: Pedigrees of the seven
families with large deletions at the KCNV2 locus. Genotypes are given for all probands for which DNA samples were available. Abbreviations of the
deletions/mutations are as follows: D1, c.19_1356+9571delinsCATTTG; D2, c.434_∗30+154del; D3, g.2696639_2713626del; D4, g.2657638_2737340del;
D5, g.2570596_2807413del; αα7dup, c.775_795dup21. “?” in the genotypes for some unaffected members in ZD283 indicates that they have not been
tested for the E148X mutation.
between the two patients is rather small with less than 300 kb in
size. Nonetheless, a common ancestry of the mutation is very likely,
since that interval is covered by 162 SNPs on the high-resolution
SNP chip.
Identification and Characterization of Large Heterozygous
Deletions at the KCNV2 Locus
During our initial screening, we found six patients with appar-
ently homozygous point mutations in exon 1 of the KCNV2 gene,
although parental consanguity was not documented in any of these
families. Family members for co-segregation analysis were available
for five of these six families. Concordant segregation of genotypes
was only observed in one family (CHRO246 which segregates the
c.1348T>A/p.Trp450Arg mutation), whereas inconsistent segrega-
tion was noted in the remaining four families (pedigrees CHRO8,
CHRO158, CHRO390, and ZD283, Fig. 1B). In all four families,
we observed that the mutation (apparently homozygous in the
patient) was only present in heterozygous state in one parent. In
order to evaluate the possibility of allelic dropout due to the pres-
ence of a heterozygous deletion, we performed qPCR-based copy
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Table 1. Mutations and Rare Sequence Variants in the KCNV2 Gene in This Study
Location Alteration nucleotide sequencea Alteration polypeptide Total no. of chromosomesb Referencec
Mutations
Exon 1 c.8_11del4 p.Lys3ArgfsX96 3 f
Exon 1 c.323_329del7 p.Tyr108TrpfsX14 1 This article
Exon 1 c.442G>T p.Glu148X 3 a, b
Exon 1 c.491T>C p.Phe164Ser 1 This article
Exon 1 c.727C>T p.Arg243Trp 1 This article
Exon 1 c.778A>T p.Lys260X 1 a, c
Exon 1 c.782C>A p.Ala261Asp 2 This article
Exon 1 c.775_795dup21 p.Ala259_Ala265dup7 1 This article
Exon 1 c.794_795dupCC p.Ser266ProfsX57 1 This article
Exon 1 c.989T>C p.Phe330Ser 1 This article
Exon 1 c.1016_1024del p.Asp339_Val341del 1 a, d
Exon 1 c.1211T>C p.Leu404Pro 1 This article
Exon 1 c.1348T>A p.Trp450Arg 2 This article
Exon 2 c.1381G>A p.Gly461Arg 4 a, b, c, f
D1: Exon 1+ c.19_1356+9571 delinsCATTTG p.Arg7HisfsX57 4 This article
D2: Exon 1+2 c.434_∗30+154del p.Glu145LeufsX4 2 This article
D3: Exon 1+ g.2696639_2713626del loss 1 ad
D4: Complete gene g.2657638_2737340del loss 1 This article
D5: Complete gene g.2570596_2807413del loss 1 This article
Rare variants
Exon 1 c.107G>A p.Arg36His 1 This article
Exon 1 c.190G>A p.Glu64Lys 1 This article
Exon 1 c.222G>C p.Glu74Asp 1 This article
Exon 1 c.328C>G p.Leu110Val 1 This article
Exon 1 c.441C>G p.Asp147Glu 1 d
Exon 1 c.725A>G p.Gln242Arg 1 This article
Exon 1 c.853A>T p.Met285Leu 1 This article
Exon 1 c.874G>A p.Gly292Ser 1 This article
Exon 1 c.1133_1141dup p.Leu381_Arg383dup 1 This article
Exon 2 c.1607A>G p.Asn536Ser 1 This article
Exon 2 c.1616T>C p.Leu539Pro 1 This article
acDNA Reference Sequence: NM_133497.3 with numbering that denotes the adenosine of the annotated translation start codon as nucleotide position +1. Genomic reference
sequence: NT_008413.18.
bChromosomes counted only for the index patients. Homozygous mutations counted as two chromosomes.
cReferences: a, Wissinger et al., 2008; b, Ben-Salah et al., 2008; c, Thiagalingan et al., 2007; d, Wu et al., 2006; e, Robson et al., 2010; f, Sergouniotis et al., 2011.
dDescribed as “gross deletion.”
number analysis for KCNV2 exon 1. This experiment showed a re-
duced copy number in all tested individuals (affected patients and
the transmitting parent) with 2–ΔΔCt values ranging between 0.51
and 0.59 (data not shown), confirming the presence of heterozygous
deletions.
For the mapping and characterization of these heterozygous
deletions, we performed intrafamilial segregation analysis of poly-
morphic markers (one STR and 29 SNPs) and qPCR-based copy
number analysis (three assays). Based on these approaches, we
were able to refine the outermost borders of the deletions in
CHRO390, ZD283, and also BD114, a family from our prior study
that segregates an as yet uncharacterized heterozygous deletion in
KCNV2 [Wissinger et al., 2008]. Subsequent LD-PCR experiments
and primer walking led to the identification of an identical in-
tragenic 11.7-kb deletion (c.434_∗30+154del) in both CHRO390
and ZD283, and a 16.9-kb deletion (Chr9:g.2696639_g.2713626del;
NCBI Build 36.1 human genome assembly) in BD114 (Supp. Fig. S1
and Fig. 2A). Whereas the first deletion has its junctions within
exon 1 and ∼150-bp downstream of exon 2, the latter encompasses
the complete exon 1 and parts of intron 1.
DeletionmappingbyqPCRand segregation analysis inCHRO158
and CHRO8 showed that in both cases the deletions were much
larger than in the other families. We therefore performed array
CGH experiments employing a chromosome 9 specific 385k Nim-
bleGen oligonucleotide array. In both cases, we observed a clear-cut
region of reduced copy number encompassing the KCNV2 locus
(Fig. 2B). We carefully examined the probes at the edges of the
deduced deletions in order to design primers for LD-PCR. This
approach eventually led to the successful amplification of junc-
tion fragments and the subsequent determination of the break-
point sequences. These experiments revealed a 79.7-kb deletion
in CHRO8 (Chr9:g.2657638_g.2737340del) and a 237-kb deletion
(Chr9:g.2570596_g.2807413del) in CHRO158 (Fig. 2 and Supp.
Fig. S1). In both instances theKCNV2 gene is completely deleted. In
CHRO158 the deletion additionally encompasses the entire VLDLR
gene, and eliminates the first exon of LOC401491/FLJ35024, a tran-
script cluster annotated as a long noncoding RNA, as well as the five
terminal coding exons of KIAA0020, a putative protein coding gene
of unknown function.
Analysis of Deletion Junctions and Putative Deletion
Mechanisms
Analysis of the deletion junctions revealed microhomology of
2 to 6bp in length and inone case an insertionof 6 bp (Supp. Fig. S1).
Five of the 10 breakpoints are located in diverse repetitive DNA
sequence elements (LINE, SINE, transposon-derived). When com-
pared with BLAST 2-Sequences, none of the breakpoint junction se-
quence pairs (±500 bp relative to each breakpoint) showed segments
of sequence homology that may be indicative for a homology-based
mechanism underlying the deletion. We therefore propose nonho-
mologous end joining (NHEJ), a mechanism that rather accurately
rejoins double-strand breaks (DSBs), as the most likely mechanism.
Notably, we have not observed recurrent independent deletions and
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Figure 2. Mapping of deletions at the KCNV2 locus. A: Overview of the size and coverage of the deletions at the KCNV2 locus in this study. B:
Deletion detection by array-based CGH. Shown are the results of the CGH performedwith a 385k chromosome 9 specific Nimblegen oligonucleotide
array. The analyzed affected family members of families CHRO8 (top) and CHRO158 (bottom) displayed clear region of reduced copy number
(averaged probe intensities) at the KCNV2 locus.
the deletions breakpoints are rather dispersed except for deletions
D1 and D3 in which breakpoints are 415 bp (telomeric side) and
1245 bp (centromeric side) apart. Moreover, there are only few copy
number variants (CNVs) fromgenome-wide studies thatmap to this
region on chromosome 9 (as listed in the UC Santa Cruz Genome
browser). These include four copy number losses (size range: 603–
20,657 bp) and three copy number gains (size range: 580–1185 bp),
all of them localize either upstream or downstream of KCNV2.
As a whole, the 237 kb region that encompasses all deletions has
a GC content of 40.4% and is enriched for repetitive sequences.
A total of 47.2% of the region does represent repetitive sequences
comparedwithanaverageof 43%forhumangenomesequenceswith
similar GC content [Smit 1999]. This difference is mainly due to a
disproportionately high number of MIR and LTR elements: 4.3%
versus 2.3% and 14.4% versus 8.6%, respectively. Yet, the increase
in repetitive sequences in the deletion region is not uniform, but
mostly restricted to the centromeric half, where its content is as
high as 56.8%. The meiotic recombination rate in that region is
rather high, on average 2.53 cM/Mb.The region contains four strong
recombinational hotspots with a recombination rate >20 cM/Mb
(Supp. Fig. S3; hotspots 1–3 and 6) and three weak hotspots with
a recombination rate >5 cM/Mb (Supp. Fig. S3; hotspots 4, 5, and
7). Notably three of the five telomeric deletion breakpoints localize
to these hotspots including D4-tel that maps to the strong hotspot
#2 and one centromeric breakpoint localizes in the close vicinity of
a weak hotspot (Supp. Fig. S3). Since NHJE involves rejoining of
DSBs one might argue that either the deletions may have occurred
duringmeiotic recombination or that recombinational hotspots per
se favor the occurrence of DSBs.
Missense Mutations in the NAB Domain Affect Assembly
with Kv2.1
Besides protein truncation mutations and larger deletions de-
scribed in this article, missensemutations do represent a substantial
fraction of all KCNV2mutations reported so far with clusters in the
pore domain and the N-terminal segment of the protein [Ben-Salah
et al., 2008; Thiagalingam et al., 2007; Wissinger et al., 2008; Wu
et al., 2006]. The N-terminal segment of voltage-gated potassium
(Kv) channels contains conserved sequence motifs (called NAB:
N-terminal A and B box domain or T1: N-terminal tetrameriza-
tion domain, Supp. Fig. S4), which are required for homomeric as
well as heteromeric channel recognition and assembly. Kv8.2 (the
gene product of KCNV2) represents a modulatory channel subunit
that is able to form heteroligomeric channels with Kv2.1 in vitro
[Czirjak et al., 2007; Ottschytsch et al., 2002]. We therefore won-
dered whether mutations in the NAB domain of Kv8.2 might affect
assembly with Kv2.1 (Supp. Fig. S4). To address this question, we
applied yeast two-hybrid technology using the Kv8.2 (αα1-250) as
prey and Kv2.1 (αα1-190) as bait. Wild-type Kv8.2 showed strong
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Figure 3. Yeast two-Hybrid phenotype of N-terminal amino acid substitution mutants in KCNV2. Yeast two-hybrid interaction assays were
performed using N-terminal fragments of Kv2.1 and Kv8.2 (gene product of KCNV2) as bait and prey, respectively. A: Qualitative assessment of
growth andα-Gal blue coloring of co-transformed yeast colonies on double and quadruple dropout mediumwith or without aureobasidin.B:Growth
of co-transformed yeasts on quadruple dropout medium including aureobasidin after 5 days at 30◦C. H, homomeric interaction with Kv2.1 as both
bait and prey; WT, wild-type Kv8.2; V, co-transformation with empty bait vector.
interaction with Kv2.1 in this assay (as assessed by colony number
and size on quadruple dropout medium, and the timing and inten-
sity of α-Galactosidase-based blue staining of colonies). In contrast,
we observed that the F164S mutant Kv8.2 fragment (representing a
novelmutationdescribed in this article) exhibit reduced interaction,
and that E184K as well as E184V mutant Kv8.2 fragments [repre-
senting two previously reported KCNV2mutations; Wissinger et al.
2008] showed no evidence of interaction with the Kv2.1 fragment
(Fig. 3). We also used this assay to analyze the functionality of two
other nonsynonymous sequence variants, L110V andD147E, which
were found as single heterozygous variants in individual patients.
We noted that the D147E variant yielded a growth and color phe-
notype that outperformed any of the Kv8.2 mutants, whereas the
L110V variant exhibit a phenotype of reduced growth comparable
with that of the F164S mutant. To quantify these results, we per-
formed interaction-based β-galactosidase activity measurements in
lysates of yeasts co-expressing Kv2.1 and wild-type or mutant Kv8.2
fragments, respectively. This assay showed a virtual absence of ac-
tivity (not significantly different from the negative control) for the
E184K and the E184V mutant, respectively, and an about 70-fold
reduced activity of both the F164S and the L110V variants compared
with the wild-type Kv8.2 protein fragment (Fig. 4). In contrast, we
found that the D147E variant exhibited an activity that is still about
one-third of the activity of the wild-type.
From these data we conclude that missense mutations that affect
the N-terminal portion of Kv8.2 interfere with the interaction be-
tween Kv8.2 and Kv2.1, and probably preclude proper assembly of
heterooligomeric channels in vivo.
Discussion
Several studies have shown that the phenotype of CDSRR is
virtually always associated with mutations in KCNV2 [Ben-Saleh
et al., 2008; Robson et al., 2010; Thiagalingan et al., 2007; Wissinger
et al., 2008; Wu et al., 2006]. However, it has not yet been investi-
gated whether mutations in KCNV2 might also cause other forms
of retinopathies, as is the case with several other retinal disease
genes (for instance mutations in ABCA4, RDS, or NR2E3). Upon
screening of a large cohort of patients with an initial diagnosis of
achromatopsia, cone dystrophy, and cone-rod dystrophy, we found
a fraction of 2.2–4.3%of patients who carried either homozygous or
compound heterozygous mutations in KCNV2. Retrospective anal-
ysis of the clinical data or clinical reinvestigation of the available
patients revealed that their phenotype was indeed fully compati-
ble with a diagnosis of CDSRR, except for one patient in which
the bright flash ERG responses were still in the normal range. It
has been reported that there is variability in the ERG responses in
CDSRR patients and the amplitude of the rod b-wave might not
be an unambiguous criterion for CDSRR. Other features such as
elevated b-/a-wave ratios in the mixed rod-cone response and the
marked prolongation of b-wave implicit times with a steep ampli-
tude versus intensity relationship might be even more helpful in the
differential diagnosis [Friedburg et al., 2007; Nagy et al., 2009].
Our study showed that CDSRR is not as rare as previously
thought. Therefore, CDSRR should be kept in mind in patients
with early onset, slowly progressive cone dystrophy and a thorough
electrophysiological examination is warranted, with an ERG which
1404 HUMANMUTATION, Vol. 32, No. 12, 1398–1406, 2011
Figure 4. Yeast two-Hybrid based β-Galactosidase activity of KCNV2
wild-type and mutants. Co-transformed Y187 yeast cells were lysed and
the β-Galactosidase activity determined by a colorimetric assay using
CPRG as substrate. Mean values and standard deviations of the activity
were calculated from duplicate measurements of three independent
colonies per co-transformation. Note that the Y-axis is interrupted to
display the high activity of the wild-type construct.
preferentially is not limited to the standard protocol recommended
by the International Society of Clinical Electrophysiology, but also
includes an intensity series in the dark-adapted patient.
A main outcome of our study is the identification and charac-
terization of larger deletions encompassing KCNV2. Except for a
homozygous deletion covering exon 2 [Robson et al., 2010] and
an uncharacterized “gross deletion” reported in our previous arti-
cle [Wissinger et al., 2008], no other larger deletions have as yet
been reported for KCNV2. Our data show that such deletions do
represent a substantial fraction of all mutant KCNV2 alleles. If we
compile the data of this and our previous study, we end up with
a prevalance of 15.5% (9/58) of large deletions among all KCNV2
mutant alleles. The identification of large deletions was largely due
to the genotyping of the parents of patients with apparently ho-
mozygous mutations. All five different deletions were much larger
than the usual amplicon size in PCR-basedmutation screenings and
would have been missed without segregation analysis. We therefore
strongly recommend that parental segregation analysis should be
performed in patients with apparently homozygous KCNV2 point
mutations. Alternatively, CNV analysis either by qPCR, multiplex
ligation-dependent probe amplification (MLPA), or CGH should
be done when samples of the parents are not available.
Two of the large deletions encompass the entire KCNV2 gene
and the remaining alleles are lacking large parts of the gene. We
therefore reason that all these deletions represent null alleles for
KCNV2. Ranging from 10.9 to 236.8 kb, the sizes of the deletions
differ considerably. Except for deletion D5, none of the others
affect additional genes besides KCNV2. D5 additionally encom-
passes the entire VLDLR gene, and parts of two hypothetical genes
(LOC401491/FLJ35024 and KIAA0020). Mutations in VLDLR have
been recently described in autosomal recessive inherited cerebel-
lar hypoplasia and mental retardation [Boycott et al., 2005], which
is also associated with quadrupedal locomotion in some pedigrees
[Ozcelik et al., 2008; Tu¨rkmen et al., 2008]. In addition and interest-
ing for ophthalmologists,Vldlr knock-out mice develop intraretinal
neovascularization with choroidal anastomosis and has been stud-
ied asmodels for retinal angiomatous proliferation (RAP), a subtype
of exudative age-related macular degeneration [Heckenlively et al,
2003; Li et al., 2007]. Not unexpectedly, there was no evidence for
either a neurological or a retinal angiogenic proliferation phenotype
in the affected patient in family CHRO158, since he is heterozygous
for the D5 deletion and carries a small 7-bp deletion in KCNV2
(c.323_329del7) on the other allele. However, due to the inclusion
of bothKCNV2 andVLDLRwithin the deletion, this singlemutation
gives rise to carriership status for multiple diseases.
We determined the telomeric as well as the centromeric break-
points of all fivedifferent deletions.Twoof thedeletions (D1andD5)
are accompanied by small insertions (6 bp and 2 bp, respectively)
of extra nucleotides at the site of deletion, whereas the remain-
ing three were precise deletions without any additional sequence
rearrangement. There were only very short stretches of 2 to 6 bp
conserved between telomeric and centromeric junctions of each
deletion, which rules out a homology-based mechanism but rather
suggests nonhomologous end joining of DSBs as the most likely
origin of the deletions.
Besides large deletions and nonsense mutations, a considerable
fraction of potentially pathogenic missense mutations in KCNV2
have been described. Although as a general practice for a reces-
sive condition, the attribute “mutation” is commonly accepted in
cases of homozygosity or in compound heterozygous state with an-
other known mutation and its exclusion in a substantial number
of controls, the additional validation by functional assays provide
a much higher level of confidence. This holds true in particular
for so-called private mutations, which have been found in single
families or individuals only. In this study and in our previous inves-
tigation we have identified several such private missense mutations,
three of them affecting amino acid residues at the N-terminus of
KCNV2 (p.Phe164Ser, p.Glu184Lys, and p.Glu184Val). All three
localize to the NAB domain of the protein that is required for recog-
nition and assembly of homo- and heterotetrameric Kv channels
[Wu et al., 1996; Xu et al., 1995; Supp. Fig. S4]. Previous studies
have shown that Kv8.2, the gene product of KCNV2, assemble with
Kv2.1 to form heterooligomeric channels with distinct biophysical
properties [Czirjak et al., 2007; Ottschytsch et al., 2002]. Using yeast
two-hybrid technology we comparatively assayed the interaction of
the NAB domain of Kv2.1 with wild-type and mutant N-terminal
fragments of Kv8.2. Our data convincingly demonstrate either a
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drastically reduced or even complete lack of interaction of all three
tested mutants compared with the wild-type fragment and thus
provide further support and evidence for the pathogenicity of these
mutations. The sensitivity of the assay prompted us to analyze two
further variants p.Leu110Val and p.Asp147Glu, unclassified rare se-
quence variant observed as single heterozygous substitutions. The
strongly reduced interaction that was observed for the p.Leu110Val
variant, suggests that this variantmost likely represents a pathogenic
mutation, although it may not account for the retinal disease in the
patient carrying thismutation, since he is lacking a secondmutation.
Based on the autosomal recessive inheritance and the large num-
ber of presumptive null alleles (e.g., complete gene deletions, early
stop or frameshiftmutations), onemight reason that CDSRR results
from the (functional) absence of the gene product. In line with this
argumentation, we suggest that Kv8.2mutants with amino acid sub-
stitutions in theNAB domain (as caused bymissensemutations) fail
to assemble with Kv2.1 that represents the most likely native coun-
terpart. This might either prohibit the formation of any functional
Kv channel or result in pure homomeric Kv2.1 channels that lack the
functional tuning of the Kv8.2 subunit for proper native function in
photoreceptors.
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